차세대 제약
칸나비노이드의 치료 잠재력 알아보기
백서: 차세대 제약
제약 제조업체가 까다로운 조건에 대한 새로운 솔루션을 모색함에 따라 칸나비노이드, 특히 칸나비디올(CBD)이 약물 혁신의 유망한 후보로 떠오르고 있습니다. 중추신경계 장애, 통증 및 암 치료에 대한 잠재력을 뒷받침하는 과학적 증거가 증가하고 규제에 대한 우호적인 발전으로 카나비노이드의 치료 가능성이 확대될 것으로 보입니다. 이 백서에서는 칸나비노이드에 대한 최신 연구를 살펴보고, 이 흥미로운 분야의 초기 단계 신약 개발을 촉진하기 위해 dsm-firmenich가 제약 업계와 어떻게 협력하고 있는지를 강조합니다. 카나비노이드 기반 치료법의 발전에 대해 자세히 알아보려면 다운로드하세요.
관련 콘텐츠
-
-
Pharma Solutions
-
CBtru®, a premium formulated cannabidiol drug intermediate
관련 문서
-
Ask-the-expert: What’s next for pharma regulations in Asia-Pacific?
Discover the top 5 trends transforming pharma regulations in Asia-Pacific and how drug developers can navigate this evolving landscape with dsm-firmenich.
-
dsm-firmenich’s API portfolio elevated by Verilege™
Simplify the drug approvals process with Verilege™, an expert services platform offering regulatory, quality, sustainability, and supply chain support for APIs.
-
Introducing dsm-firmenich’s new portfolio of taste solutions for pharmaceutical formulations
Discover our novel portfolio offering for the pharmaceutical market, which aims to address a growing need for full-service flavor solutions and taste modulation strategies.
How can we help you?
-
New partnership request
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
-
Sample request
Don’t just take our word for it. Discover how our solutions can support your product development journey.
-
Quick links
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.